Mary E. Rosandich

536 citations
9 papers · 389 indexed · h-index 8
Topics
HIV Research and Treatment (6 papers)HIV/AIDS drug development and treatment (4 papers)Immune Cell Function and Interaction (3 papers)

In The Last Decade

Mary E. Rosandich

9 papers receiving 370 citations

Peers

Mary E. Rosandich
Comparison fields: 5 of 72
  • Immunology 91
  • Molecular Biology 86
  • Infectious Diseases 76
  • Virology 73
  • Physiology 64
Replace Dawn Smith with:
Dawn Smith United States
L. Almulki United States
Linda Ye United States
Luge Li United States
Angela Robbiano Italy
Godhev K. Manakkat Vijay United Kingdom
Joshua J. Michel United States
Domenico Lo Tartaro Italy
Émilie Capel France
Lorenzo Raeli Italy
Mary E. Rosandich relative to Dawn Smith United States Dawn Smith's profile →
Citations per field
00.5×3.3×
Dawn Smith · 1×
Citations per year

Countries citing papers authored by Mary E. Rosandich

Since Specialization
Citations

This map shows the geographic impact of Mary E. Rosandich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Rosandich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Rosandich more than expected).

Fields of papers citing papers by Mary E. Rosandich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Rosandich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Rosandich. The network helps show where Mary E. Rosandich may publish in the future.

Co-authorship network of co-authors of Mary E. Rosandich

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Rosandich. A scholar is included among the top collaborators of Mary E. Rosandich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Rosandich. Mary E. Rosandich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 4
2 11
3 38
4 11
5 10
6 19
7 196
8 83
9 17

About Mary E. Rosandich

Mary E. Rosandich is a scholar working on Virology, Immunology and Infectious Diseases, having authored 9 papers that have together received 389 indexed citations. Recurring topics across this work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Virology (73 citations), Immunology (91 citations) and Infectious Diseases (76 citations). Mary E. Rosandich has collaborated with scholars based in United States, Italy and Philippines. Frequent co-authors include Charles A. Dinarello, Carl W. White, Pietro Ghezzi, Marina Bianchi, Jonathan A. Leff, John E. Repine, Lance S. Terada, Glenn W. Kindt, Daniel R. Kuritzkes and David A. Norris. Their work appears in journals such as Blood, The Journal of Infectious Diseases and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026